Trial · NCT01940471
Participant flow24
How many started, completed or left each group, period by period.
1 to 20 of 24
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Period 1: Double-blind Phase | STARTED | TAF 25 mg | 582 | |
| Period 1: Double-blind Phase | STARTED | TDF 300 mg | 293 | |
| Period 1: Double-blind Phase | STARTED | TAF 25 mg to TAF 25 mg | 0 | |
| Period 1: Double-blind Phase | STARTED | TDF 300 mg to TAF 25 mg | 0 | |
| Period 1: Double-blind Phase | COMPLETED | TAF 25 mg | 515 | |
| Period 1: Double-blind Phase | COMPLETED | TDF 300 mg | 253 | |
| Period 1: Double-blind Phase | COMPLETED | TAF 25 mg to TAF 25 mg | 0 | |
| Period 1: Double-blind Phase | COMPLETED | TDF 300 mg to TAF 25 mg | 0 | |
| Period 1: Double-blind Phase | NOT COMPLETED | TAF 25 mg | 67 | |
| Period 1: Double-blind Phase | NOT COMPLETED | TDF 300 mg | 40 | |
| Period 1: Double-blind Phase | NOT COMPLETED | TAF 25 mg to TAF 25 mg | 0 | |
| Period 1: Double-blind Phase | NOT COMPLETED | TDF 300 mg to TAF 25 mg | 0 | |
| Period 2: Open-Label TAF Extension Phase | STARTED | TAF 25 mg | 0 | |
| Period 2: Open-Label TAF Extension Phase | STARTED | TDF 300 mg | 0 | |
| Period 2: Open-Label TAF Extension Phase | STARTED | TAF 25 mg to TAF 25 mg | 514 | |
| Period 2: Open-Label TAF Extension Phase | STARTED | TDF 300 mg to TAF 25 mg | 253 | |
| Period 2: Open-Label TAF Extension Phase | COMPLETED | TAF 25 mg | 0 | |
| Period 2: Open-Label TAF Extension Phase | COMPLETED | TDF 300 mg | 0 | |
| Period 2: Open-Label TAF Extension Phase | COMPLETED | TAF 25 mg to TAF 25 mg | 422 | |
| Period 2: Open-Label TAF Extension Phase | COMPLETED | TDF 300 mg to TAF 25 mg | 213 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01940471/flow